Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study-Reference-Cited by-同舟云学术

Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study

Published:2024-03-02 Issue:3 Volume:11 Page:501-521
ISSN:2198-6576
Container-title:Rheumatology and Therapy
language:en
Short-container-title:Rheumatol Ther

Author:

Frade-Sosa Beatriz^ORCID,Ponce Andrés^ORCID,Ruiz-Ortiz Estíbaliz,De Moner Noemí,Gómara María J.,Azuaga Ana Belén,Sarmiento-Monroy Juan C.^ORCID,Morlà Rosa^ORCID,Ruiz-Esquide Virginia^ORCID,Macías Laura^ORCID,Sapena Nuria,Tobalina Lola,Ramirez Julio,Cañete Juan D.^ORCID,Yague Jordi^ORCID,Auge Josep M.^ORCID,Gomez-Puerta José A.^ORCID,Viñas Odette^ORCID,Haro Isabel^ORCID,Sanmarti Raimon^ORCID

Funder

Openbanak

Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40744-024-00650-9.pdf

Reference50 articles.

1. Scherer HU, Häupl T, Burmester GR. The etiology of rheumatoid arthritis. J Autoimmun. 2020;110: 102400.

2. van Vollenhoven R. Treat-to-target in rheumatoid arthritis—are we there yet? Nat Rev Rheumatol. 2019;15:180–6.

3. Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79:S685–99.

4. Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75:3–15.

5. Aletaha D, Smolen JS. The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheumatic Disease Clinics of North America. Rheum Dis Clin North Am. 2006;32(1):9–44.